Menopause

Astellas announced positive data from its study investigating the long-term safety of fezolinetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.

More than half of postmenopausal women experience female pattern hair loss, according to a cross-sectional study in the journal Menopause.

Risk assessment, lifestyle counseling, adverse effects, and medication management.

Women with severe menopausal symptoms are likely to experience significantly greater cognitive decline than their counterparts with mild menopausal symptoms, according to a cross-sectional study in the journal Menopause.

New study results suggest that severe depression and sexual dysfunction, in particular, can affect a woman's attention, language, orientation, recall, registration, and visuospatial skills.

Being Non-Hispanic (N-H) Asian is a significant influencing factor for the number of gastrointestinal (GI) symptoms and the severity scores of GI symptoms, according to a study of 4 major racial/ethnic groups of midlife women in the United States.

According to a recent study, women who experience stable menstrual cycles during the menopause transition have a significantly higher cardiovascular disease (CVD) risk later in life than those who have a late increase in cycle length.

A study in JAMA Network Open has concluded that women who undergo bilateral oophorectomy before menopause are significantly more likely to develop mild cognitive impairment and poorer performance on cognitive tests about 30 years later compared to women who do not have the procedure.

Certain post-menopausal women with HR-positive, HER2-negative breast cancer may be able to only undergo endocrine therapy after surgery – sparing themselves from the chemotherapy side effects.

For women with postmenopausal vaginal symptoms, fractional carbon dioxide laser versus sham treatment fails to significantly improve vaginal symptoms after 12 months, according to the results of a randomized controlled trial in JAMA.

Vasomotor symptoms (VMS) are significantly less common in menopausal women with sarcopenia than in those without, according to a study conducted in the Republic of Korea.

Midlife women with early-stage vision impairment are significantly more likely to develop depressive symptoms, according to a study in the journal Menopause, which used data from the Michigan site of the Study of Women’s Health Across the Nation (SWAN).

Margo B. Minissian, PhD, shares key updates from the newest recommendations for primary prevention of cardiovascular disease in women from the ACC and AHA. Minissian is executive director, Geri & Richard Brawerman Nursing Institute at Cedars-Sinai Medical Center and the Simms/ Mann Endowed Chair of Nursing Education, Innovation and Research at Cedars-Sinai Medical Center.

Past president Sheryl Kingsberg, PhD, discusses the paper she chose to present as paper of the year at NAMS 2021.

We caught up with Risa Kagan, MD, at the North American Menopause Society's 2021 Annual Meeting to hear about her role on the Scientific Planning Committee and this year's takeaways.

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

Oral contraceptives are not linked to early natural menopause, according to a population-based study in the journal Human Reproduction.

A more standardized approach to menopause preparedness, including educating both patients and providers, is needed to improve care and quality of life for individuals during and after menopause, according to a study in the journal Menopause.

In an analysis of SWAN data, investigators found changes in menstrual cycle length within the 5 years preceding a woman's final menstrual period was associated with changes in carotid intima-media thickness and brachial-ankle pulse wave velocity.

Barb Dehn, NP, discusses vaccine hesitancy, soy and estrogen receptors, and a hospital in Tanzania dedicated to improving women's health through quality health care and education in under-resourced communities.

Kara L. Marlatt, PhD, MPH, tells Contemporary OB/GYN® about the exciting new anti-obesity and weight loss drugs to watch for.

Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

A study published in The BMJ reveals that menopausal hormone therapy is not linked to an increased risk of developing dementia in women.

Premature menopause is significantly linked to eventual atherosclerotic cardiovascular disease (ASCVD), according to a research letter in JAMA Cardiology.

CRISPR gene-editing technology holds the potential to usher in a new age in medicine, according to a featured speaker at the North American Menopause Society Annual Meeting, being held this week in Washington, D.C.